Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab (DEMAND)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04224636
Recruitment Status : Recruiting
First Posted : January 13, 2020
Last Update Posted : October 26, 2020
Sponsor:
Information provided by (Responsible Party):
Enrico De Toni, Ludwig-Maximilians - University of Munich

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 1, 2025
Estimated Study Completion Date : March 1, 2025